The Food and Drug Administration (FDA, the Agency, or we) is announcing a request for information from interested parties and the public to share their perspectives with FDA on testosterone replacement therapy for men. The Agency intends to use the information submitted to help inform considerations related to testosterone therapy for men.
| Document Number | 2025-22466 |
| FR Citation | 90 FR 57474 |
| Type | Notice |
| Published | Dec 11, 2025 |
| Effective Date | - |
| RIN | - |
| Docket ID | Docket No. FDA-2025-N-6743 |
| Pages | 57474–57476 (3 pages) |
| Text Fetched | No |
| Part | Name | Agency |
|---|---|---|
| No linked CFR parts | ||
| Type | Proposed | Final | Method | Conf |
|---|---|---|---|---|
| No paired documents | ||||
The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.